Want to see TSE:VIBE full AI Analyst Report?

Vibe Bioscience Ltd (VIBE) Price & Analysis

9 Followers

VIBE Stock Chart & Stats

C$0.45

C$0.05(12.50%)

At close: Jun 26 4:00 PM EDT

C$0.45

C$0.05(12.50%)

Day’s Range― - ―

52-Week RangeC$0.30 - C$0.95

Previous CloseN/A

Volume500.00

Average Volume (3M)6.19K

Market Cap

C$485.87K

Enterprise ValueC$2.49

Total Cash (Recent Filing)C$909.58K

Total Debt (Recent Filing)C$2.38M

Price to Earnings (P/E)―

Beta2.20

Next Earnings

Aug 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.51

Shares Outstanding1,079,699

10 Day Avg. Volume10,465

30 Day Avg. Volume6,194

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)>-0.01

Price to Sales (P/S)0.00224

P/FCF Ratio2.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue & Margin ImprovementA large TTM revenue rebound alongside ~43% gross margin and positive EBIT/EBITDA signals improving unit economics and commercial traction. These structural improvements support sustainable margin expansion and better profitability prospects over coming quarters, enabling reinvestment.

Positive Operating & Free Cash FlowThe shift to positive operating and free cash flow marks a durable structural change versus prior years, demonstrating the business can internally fund some operations and modest investments. Consistent cash generation improves financing flexibility and resilience over the medium term.

Modest And Declining DebtRelatively low absolute debt and a declining trend reduce fixed financing burdens and default risk, giving management room to prioritize R&D or commercialization. For a specialty drug manufacturer, manageable leverage supports endurance through clinical or regulatory cycles.

Bears Say

Negative Shareholders' EquityNegative shareholders' equity reflects multi-year accumulated losses and a thin capital cushion, constraining ability to absorb shocks or pursue opportunistic investments. It raises dilution risk from future equity raises and limits strategic and financing flexibility over the medium term.

Ongoing Net Losses & Revenue VolatilityDespite operational improvements, the company remains net loss-making with a negative TTM net margin and historically volatile revenue. This undermines earnings predictability and could constrain sustained investment in commercialization or R&D without continued improvement.

Small, Inconsistent Cash CushionPositive cash flow is encouraging but small relative to the revenue base and inconsistent historically. That limited cushion leaves the company exposed to working capital swings, clinical or regulatory delays, or step-up in R&D spending, possibly forcing external funding under strain.

Vibe Bioscience Ltd News

Vibe Growth Director to Reduce Stake with Share Sale

Vibe Bioscience Ltd ( ($TSE:VIBE) ) has shared an update. Mark Waldron, a director at Vibe Growth Corporation,...

1y ago

Vibe Growth Plans Strategic Share Consolidation

Vibe Bioscience Ltd (TSE:VIBE) has released an update. Vibe Growth Corporation, a leading cannabis company, has announced a...

2y ago

VIBE

VIBE FAQ

What was Vibe Bioscience Ltd’s price range in the past 12 months?

Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$0.95 in the past 12 months.

What is Vibe Bioscience Ltd’s market cap?

Vibe Bioscience Ltd’s market cap is C$485.87K.

When is Vibe Bioscience Ltd’s upcoming earnings report date?

Vibe Bioscience Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 8 days.

How were Vibe Bioscience Ltd’s earnings last quarter?

Currently, no data Available

Is Vibe Bioscience Ltd overvalued?

According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vibe Bioscience Ltd pay dividends?

Vibe Bioscience Ltd does not currently pay dividends.

What is Vibe Bioscience Ltd’s EPS estimate?

Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vibe Bioscience Ltd have?

Vibe Bioscience Ltd has 1,079,699 shares outstanding.

What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vibe Bioscience Ltd?

Currently, no hedge funds are holding shares in TSE:VIBE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vibe Bioscience Ltd

Vibe Growth Corp. is a vertically integrated cannabis company. The firm operates retail dispensaries, cannabis greenhouse and indoor cultivation, commercial distribution and transportation, e-commerce and home delivery, and manufacturing of marijuana products. It operates through the following segments: Dispensaries, Cultivation, Real Estate, and Canada. The company was founded on January 19, 2011 and is headquartered in Vancouver, Canada.